Microbial Cell Factories · 2024 · 18 citations · 35 references
Life SciencesBiotechnologyMicrobiologyMetabolic EngineeringMetabolismMicrobial MetabolismBiotransformation PathwaysFlavonoid BiosynthesisMetabolic Pathway EngineeringMicrobial BiotransformationMicrobial Metabolic EngineeringMicrobial Natural Product BiosynthesisBacillus SubtilisBiotransformationCombinatorial BiotransformationGlycosyltransferase-mediated BiosynthesisHeterologous Expression SystemsHeterologous Gene ExpressionMetabolic Engineering For BiotransformationMetabolite Biotransformation
BACKGROUND: Isoquercitrin (quercetin-3-O-β-D-glucopyranoside) has exhibited promising therapeutic potentials as cardioprotective, anti-diabetic, anti-cancer, and anti-viral agents. However, its structural complexity and limited natural abundance make both bulk chemical synthesis and extraction from medical plants difficult. Microbial biotransformation through heterologous expression of glycosyltransferases offers a safe and sustainable route for its production. Despite several attempts reported in microbial hosts, the current production levels of isoquercitrin still lag behind industrial standards. RESULTS: Herein, the heterologous expression of glycosyltransferase UGT78D2 gene in Bacillus subtilis 168 and reconstruction of UDP-glucose (UDP-Glc) synthesis pathway led to the synthesis of isoquercitrin from quercetin with titers of 0.37 g/L and 0.42 g/L, respectively. Subsequently, the quercetin catabolism blocked by disruption of a quercetin dioxygenase, three ring-cleavage dioxygenases, and seven oxidoreductases increased the isoquercitrin titer to 1.64 g/L. And the hydrolysis of isoquercitrin was eliminated by three β-glucosidase genes disruption, thereby affording 3.58 g/L isoquercitrin. Furthermore, UDP-Glc pool boosted by pgi (encoding glucose-6-phosphate isomerase) disruption increased the isoquercitrin titer to 10.6 g/L with the yield on quercetin of 72% and to 35.6 g/L with the yield on quercetin of 77.2% in a 1.3-L fermentor. CONCLUSION: The engineered B. subtilis strain developed here holds great potential for initiating the sustainable and large-scale industrial production of isoquercitrin. The strategies proposed in this study provides a reference to improve the production of other flavonoid glycosides by engineered B. subtilis cell factories.
35
Cre/ <i>lox</i> System and PCR-Based Genome Engineering in <i>Bacillus subtilis</i>
Xin Yan, Haojie Yu, Qing Hong et al. · Applied and Environmental Microbiology · 2008 · 227 citations